Abstract
Background
Secondary damage due to neurochemical and inflammatory changes in the penumbra in the first days after ischemic stroke contributes substantially to poor clinical outcome. In animal models, vagus nerve stimulation (VNS) inhibits these detrimental changes and thereby reduces tissue injury. The aim of this study is to investigate whether non-invasive cervical VNS (nVNS) in addition to the current standard treatment can improve penumbral recovery and limit final infarct volume.
Methods
NOVIS is a single-center prospective randomized clinical trial with blinded outcome assessment. One hundred fifty patients will be randomly allocated (1:1) within 12 h from clinical stroke onset to nVNS for 5 days in addition to standard treatment versus standard treatment alone. The primary endpoint is the final infarct volume on day 5 assessed with MRI.
Discussion
We hypothesize that nVNS will result in smaller final infarct volumes as compared to standard treatment due to improved penumbral recovery. The results of this study will be used to assess the viability and approach to power a larger trial to more definitively assess the clinical efficacy of nVNS after stroke.
Trial registration
ClinicalTrials.govNCT04050501. Registered on 8 August 2019
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; van Walderveen, Marianne A. A. 2 ; Kruyt, Nyika D. 1 ; van Zwet, Erik W. 3 ; Liebler, Eric J. 4 ; Ferrari, Michel D. 1 ; Wermer, Marieke J. H. 1 1 Leiden University Medical Center, Department of Neurology, Leiden, the Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
2 Leiden University Medical Center, Department of Radiology, Leiden, the Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
3 Leiden University Medical Center, Department of Medical Statistics, Leiden, the Netherlands (GRID:grid.10419.3d) (ISNI:0000000089452978)
4 electroCore, Inc, Basking Ridge, USA (GRID:grid.10419.3d)




